Trials / Conditions / Tyrosine Kinase Inhibitors

Tyrosine Kinase Inhibitors

4 registered clinical trials studyying Tyrosine Kinase Inhibitors — 2 currently recruiting.

Status	Trial	Sponsor	Phase
Recruiting	Analysis of Circulating Tumor DNA Dynamics to Predict and Monitor Response to TKI in Patients With Advanced NS NCT06167460	Gene Solutions	—
Recruiting	Discontinuation of TyrosIne Kinase Inhibitors (TKI) in Chronic Myeloid Leukemia (CML) and Impact on the Immune NCT05753384	Poitiers University Hospital	Phase 3
Unknown	Treatment With Olverembatinib in CML-CP Patients Who Failed to at Least Two Previously Administered Second-gen NCT05311943	Shenzhen Second People's Hospital	Phase 3
Completed	CECT Features of MVI Predict Response to TACE Plus TKI in Intermediate-stage HCC NCT07449065	First Affiliated Hospital, Sun Yat-Sen University	—